Anvisa registra duas novas canetas de semaglutida
Safety Classified by Officially
Produtos são indicados para o tratamento de diabetes e têm como matriz o medicamento Owozy
Read the original at the source: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2026/anvisa-registra-duas-novas-canetas-de-semaglutida
Officially imported this from Agência Nacional de Vigilância Sanitária (Anvisa)’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
This publication has changed since it was first published
2 versions recorded. The original is kept in full — nothing is overwritten.
- v2 imported change on current
- v1 as first published on
Provenance
- Organization
- Agência Nacional de Vigilância Sanitária (Anvisa) — imported from official source
- Official source
- https://www.gov.br/anvisa/++api++/@search?portal_type=News%20Item&sort_on=effective&sort_order=reverse&b_size=25&metadata_fields=effective&metadata_fields=UID API
- Imported
- November 10, 2026 13:02
- Versions
- 2 recorded
- Identity
-
6232058bd5564c2e8fb4d64c7a0e5ce6